Eleonora Cannas

Here below are the publications (1) participated by Eleonora Cannas along with Alberto J. Arribas (as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations).

Any wrong or incomplete data? Any missing, misplaced, unlicensed picture? Please report any abuse, inaccuracy or lack of information to info@ticinoscienza.ch

1) PI3Kδ activation, IL6 overexpression, and CD37 loss cause resistance to naratuximab emtansine in lymphomas

Blood Advances, 7 ottobre 2024

Facts & figures

Eleonora Cannas has coordinated or participated in 3 publications
(as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations) whose subjects can be represented by this 9 elements tag cloud:

B cell lymphoid (1) BET (1) bromodomain (1) bromodomain-containing protein 4 (1) diffuse large B-cell lymphoma (1) epigenetics (1) immuno-oncology (1) lymphoma (1) proteolysis-targeting chimeras (1)

Eleonora Cannas has coordinated or participated in 3 publications (as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations) featured by 3 scientific journals:

bioRxiv (1) Blood Advances (1) Exploration of Targeted Anti-tumor Therapy (1)

Eleonora Cannas has coordinated or participated in 3 publications (as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations) involving also 25 co-authors being active in Ticino:

Luciano Cascione (3) Francesco Bertoni (3) Emanuele Zucca (3) Andrea Rinaldi (3) Anastasios Stathis (3) Sara Napoli (3) Eugenio Gaudio (3) Chiara Tarantelli (3) Roberta Bordone Pittau (2) Davide Rossi (2) Georg Stüssi (2) Alberto J. Arribas (1) Ivo Kwee (1) Laura Barnabei (1) Filippo Spriano (1) Afua Adjeiwaa Mensah (1) Cesare Rech (1) Nicolas Munz (1) Jacopo Sgrignani (1) Sandra Jovic (1) Giulio Sartori (1) Alberto Jesus Arribas (1) Hillarie Ekeh (1) Andrea Cavalli (1) Carmelo Moscatello (1)

Eleonora Cannas has coordinated or participated in 3 pubblications (as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations) in whose synopsis the 23 most frequently used terms (excluding 22 not relevant terms) are here listed:

E.C. WORD CLOUD pi (2) overexpression (1) cause (1) naratuximab (1) emtansine (1) lymphomas (1) bromodomain (1) extra-terminal (1) degrader (1) mz (1) exhibits (1) preclinical (1) anti-tumoral (1) b-cell (1) lymphoma (1) cell-like (1) erbb (1) mediated (1) signaling (1) mediator (1) btk (1) lymphoid (1) neoplasms (1)

In the synopsis of the whole 3132 pubblications (as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations), the 171 most frequently used terms (excluding 22 not relevant or unfrequently used terms (terms used less than 10 times) are here listed:

THE WHOLE WORD CLOUD cancer (279) covid- (182) thyroid (108) pet (101) sars-cov- (101) prostate (99) cardiac (97) hiv (81) atrial (75) coronary (75) breast (74) pandemic (67) sclerosis (67) lymphoma (66) fibrillation (65) bone (53) aortic (51) artery (49) heart (48) stroke (46) liver (45) brain (43) carcinoma (43) antibodies (41) lung (38) mri (38) cardiovascular (36) transcatheter (35) ventricular (35) nodules (34) dna (34) virus (33) extracellular (32) metastatic (32) myocardial (31) tumor (30) oncology (29) kidney (28) ultrasound (28) knee (26) esmo (26) f-fdg (26) antibody (26) vesicles (25) spinal (25) mitral (25) hepatitis (24) ischemic (23) cervical (23) infarction (22) tuberculosis (22) ehra (22) antiplatelet (22) diabetes (22) sperm (22) pulmonary (21) radiotherapy (21) chemotherapy (21) renal (21) ovarian (21) percutaneous (21) implantation (20) vaccination (20) sentinel (20) osteoarthritis (19) blood (19) nuclear (18) urinary (18) transplantation (18) tomography (18) pacing (18) tumors (18) bacterial (18) b-cell (17) resonance (17) endovascular (17) monoclonal (17) bladder (17) lymph (17) laparoscopic (17) colorectal (17) mice (17) coronavirus (16) immunodeficiency (16) musculoskeletal (15) vascular (15) fdg (15) implantable (15) lymphomas (14) transplant (14) vaccine (14) fractures (14) peripheral (14) neurocognitive (14) leukemia (14) biomarker (13) nerve (13) pneumonia (13) biomarkers (13) radiomics (13) metabolic (13) tricuspid (13) plasma (13) preclinical (13) metabolism (13) serum (13) metastasis (13) pregnancy (13) lymphocytic (13) autoimmune (12) malignancy (12) membrane (12) grafts (12) ischemia (12) endometrial (12) fna (12) joint (12) brugada (12) antiretroviral (12) legs (12) male (12) arterial (12) dementia (12) esc (12) hemorrhage (12) behavior (12) mrna (12) pi (11) burden (11) cytology (11) signaling (11) pathways (11) contemporary (11) adherence (11) catheter (11) contrast-enhanced (11) limb (11) tau (11) parkinson (11) conference (11) radiation (11) senescence (11) neck (11) hiv- (11) mesenchymal (11) lockdown (11) mutations (11) medullary (11) il- (11) igg (10) intravenous (10) arrhythmia (10) vitamin (10) interventions (10) prophylaxis (10) migraine (10) follicular (10) gastric (10) prognosis (10) metastases (10) skin (10) incontinence (10) muscle (10) anesthesia (10) epidemiology (10) lipid (10) baseline (10) refractory (10) malignant (10) occlusion (10) dynamic (10)

Scientific researchers in Ticino

Eleonora Cannas has participated - as a whole - in 3 publications (as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations) - here below are the ones participated along with Alberto J. Arribas

1) PI3Kδ activation, IL6 overexpression, and CD37 loss cause resistance to naratuximab emtansine in lymphomas

Eleonora Cannas has participated - as a whole - in 3 publications
(as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations) - here below are the ones participated along with Alberto J. Arribas